Comparative effectiveness of a bilayered living cellular construct and an acellular fetal bovine collagen dressing in the treatment of venous leg ulcers
Publication: Journal of Comparative Effectiveness Research
Abstract
Aim: To compare the effectiveness of bilayered living cellular construct (BLCC) and an acellular fetal bovine collagen dressing (FBCD) for the treatment of venous leg ulcers. Methods: Data from WoundExpert® (Net Health, PA, USA) was used to analyze 1021 refractory venous leg ulcers treated at 177 facilities. Results: Kaplan–Meier analyses showed that BLCC (893 wounds) was superior to FBCD (128 wounds), p = 0.01 for: wound closure by weeks 12 (31 vs 25%), 24 (55 vs 43%) and 36 (68 vs 53%); reduction in time to wound closure of 37%, (19 vs 30 weeks); and improvement in the probability of healing by 45%. Conclusion: BLC versus FBCD showed significant differences in both time to and frequency of healing suggesting that BLCC may provide significant cost savings compared with FBCD.
Formats available
You can view the full content in the following formats:
References
Papers of special note have been highlighted as: • of interest; •• of considerable interest
1.
Valencia IC, Falabella A, Kirsner RS, Eaglstein WH. Chronic venous insufficiency and venous leg ulceration. J. Am. Acad. Dermatol. 44(3), 401–421 (2001).
2.
Sen CK, Gordillo GM, Roy S et al. Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen. 17(6), 763–771 (2009).
3.
Fife C, Walker D, Thomson B, Carter M. Limitations of daily living activities in patients with venous stasis ulcers undergoing compression bandaging: problems with the concept of self-bandaging. Wounds 19(10), 255–257 (2007).
4.
Hankin CS, Knispel J, Lopes M, Bronstone A, Maus E. Clinical and cost efficacy of advanced wound care matrices for venous ulcers. J. Manag. Care Pharm. 18(5), 375–384 (2012).
5.
Fowkes FG, Evans CJ, Lee AJ. Prevalence and risk factors of chronic venous insufficiency. Angiology 52(Suppl. 1), S5–S15 (2001).
6.
Margolis DJ, Bilker W, Santanna J, Baumgarten M. Venous leg ulcer: incidence and prevalence in the elderly. J. Am. Acad. Dermatol. 46(3), 381–386 (2002).
7.
Rice JB, Desai U, Cummings AK, Birnbaum HG, Skornicki M, Parsons N. Medical, drug, and work-loss costs of venous leg ulcers. Value Heal. 16(3), A73 (2013).
8.
O’Meara S, Cullum NA, Nelson EA. Compression for venous leg ulcers. Cochrane Database Syst. Rev. 1, CD000265 (2009).
9.
Kurz X, Kahn SR, Abenhaim L et al. Chronic venous disorders of the leg: epidemiology, outcomes, diagnosis and management. Summary of an evidence-based report of the VEINES task force. Venous insufficiency epidemiologic and economic studies. Int. Angiol. 18(2), 83–102 (1999).
10.
Falanga V, Margolis D, Alvarez O et al. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Arch. Dermatol. 134(3), 293–300 (1998).
•• The landmark paper of the randomized controlled trial of bilayer living cellular construct for the treatment of venous leg ulcers when compared with an active control (compression therapy) that reports safety and efficacy.
11.
Falanga V, Sabolinski M. A bilayered living skin construct (APLIGRAF®) accelerates complete closure of hard-to-heal venous ulcers. Wound Repair Regen. 7(4), 201–207 (1999).
12.
Falanga V, Sabolinski ML. Prognostic factors for healing of venous and diabetic ulcers. Wounds 12(5 Suppl. A), A42–A46 (2000).
13.
Gelfand JM, Hoffstad O, Margolis DJ. Surrogate endpoints for the treatment of venous leg ulcers. J. Invest. Dermatol. 119(6), 1420–1425 (2002).
14.
Karr JC. Retrospective comparison of diabetic foot ulcer and venous stasis ulcer healing outcome between a dermal repair scaffold (PriMatrix) and a bilayered living cell therapy (Apligraf). Adv. Skin Wound Care 24(3), 119–125 (2011).
15.
Toh S, García Rodríguez LA, Hernán MA. Analyzing partially missing confounder information in comparative effectiveness and safety research of therapeutics. Pharmacoepidemiol. Drug Saf. 21(Suppl. 2), 13–20 (2012).
16.
Kerstein MD, Brem H, Giovino KB, Sabolinski M. Development of a severity scale for evaluating the need for Graftskin in nonhealing venous ulcers. Adv. Ski. Wound Care 15(2), 66–71 (2002).
17.
Margolis DJ, Allen-Taylor L, Hoffstad O, Berlin JA. The accuracy of venous leg ulcer prognostic models in a wound care system. Wound Repair Regen. 12(2), 163–168 (2004).
18.
Eaglstein WH, Kirsner RS. Expectations for comparative effectiveness and efficacy research. JAMA Dermatol. 149(1), 18 (2013).
• An important, general publication in the field of Comparative Effectiveness Research that explains the strengths and potential limitations inherent in Comparative Effectiveness Research studies.
19.
van Staa T-P, Leufkens HG, Zhang B, Smeeth L. A comparison of cost effectiveness using data from randomized trials or actual clinical practice: selective Cox-2 inhibitors as an example. PLoS Med. 6(12), e1000194 (2009).
20.
Concato J. When to randomize, or ‘evidence-based medicine needs medicine-based evidence’. Pharmacoepidemiol. Drug Saf. 21(Suppl. 2), 6–12 (2012).
21.
Institute of Medicine. Initial National Priorities for Comparative Effectiveness Research. National Academies Press, DC, USA (2009).
22.
Gandjour A. Prioritizing comparative effectiveness research: are drug and implementation trials equally worth funding? Pharmacoeconomics 29(7), 555–561 (2011).
23.
Gillespie DL, Kistner B et al. Writing Group III of the Pacific Vascular Symposium 6. Venous ulcer diagnosis, treatment, and prevention of recurrences. J. Vasc. Surg. 52(5 Suppl.), S8–S14 (2010).
24.
González-Consuegra RV, Verdú J. Quality of life in people with venous leg ulcers: an integrative review. J. Adv. Nurs. 67(5), 926–944 (2011).
25.
Rice JB, Desai U, Cummings AKG, Birnbaum HG, Skornicki M, Parsons N. Burden of venous leg ulcers in the United States. J. Med. Econ. 17(5), 347–356 (2014).
•• Provides a detailed analysis of the costs of treating open venous leg ulcers.
Information & Authors
Information
Published In
Pages: 797 - 805
PubMed: 29809059
Copyright
© 2018 Michael L Sabolinski.
History
Received: 6 April 2018
Accepted: 10 May 2018
Published online: 29 May 2018
Keywords:
Topics
Authors
Metrics & Citations
Metrics
Article Usage
Article usage data only available from February 2023. Historical article usage data, showing the number of article downloads, is available upon request.
Citations
How to Cite
Comparative effectiveness of a bilayered living cellular construct and an acellular fetal bovine collagen dressing in the treatment of venous leg ulcers. (2018) Journal of Comparative Effectiveness Research. DOI: 10.2217/cer-2018-0031
Export citation
Select the citation format you wish to export for this article or chapter.
Citing Literature
- Yunyao Bo, Zehui Zhou, Ruitong Dong, Li Sun, Chenxi Li, Lin Zhang, Yuan Yan, Silk fibroin nanofibers-GelMA hydrogel composite loaded with embryonic fibroblasts: A strategy for enhanced wound healing, Colloids and Surfaces B: Biointerfaces, 10.1016/j.colsurfb.2026.115581, 263, (115581), (2026).
- Oscar M Alvarez, Tad Archambault, Michael L Sabolinski, Comparative effectiveness study of a bilayer cellular construct and dehydrated human amnion/chorion membrane in the treatment of pressure injuries, Journal of Wound Care, 10.12968/jowc.2024.0070, 34, 8, (616-622), (2025).
- Shawn M Cazzell, Joseph Caporusso, Dean Vayser, R Daniel Davis, Oscar M Alvarez, Michael L Sabolinski, Dehydrated Amnion Chorion Membrane versus standard of care for diabetic foot ulcers: a randomised controlled trial, Journal of Wound Care, 10.12968/jowc.2024.0139, 33, Sup7, (S4-S14), (2024).
- Ali Esmaeili, Masoud Soleimani, Maryam Rouhani, Ghasem Noorkhajavi, Seyed Mohsen Aghaei-Zarch, Behnam Hasannejad-Asl, Saeid Bagheri-Mohammadi, Maryam Ebrahimi, Saeed Heidari Keshel, Xenograft-based skin substitutes: A critical review, Journal of Drug Delivery Science and Technology, 10.1016/j.jddst.2024.105613, 95, (105613), (2024).
- Nathaniel R. Primous, Peter T. Elvin, Kathleen V. Carter, Hagner L. Andrade, Javier La Fontaine, Naohiro Shibuya, Claudia C. Biguetti, Bioengineered Skin for Diabetic Foot Ulcers: A Scoping Review, Journal of Clinical Medicine, 10.3390/jcm13051221, 13, 5, (1221), (2024).
- Michael L Sabolinski, Tad Archambault, Real-world data analysis of bilayered living cellular construct and fetal bovine collagen dressing treatment for pressure injuries: a comparative effectiveness study, Journal of Comparative Effectiveness Research, 10.57264/cer-2023-0109, 13, 4, (2024).
- Maryam Kaviani, Bita Geramizadeh, Basic Aspects of Skin Tissue Engineering: Cells, Biomaterials, Scaffold Fabrication Techniques, and Signaling Factors, Journal of Medical and Biological Engineering, 10.1007/s40846-023-00822-y, 43, 5, (508-521), (2023).
- Prarthana Patil, Katherine A. Russo, Joshua T. McCune, Alonda C. Pollins, Matthew A. Cottam, Bryan R. Dollinger, Carlisle R. DeJulius, Mukesh K. Gupta, Richard D’Arcy, Juan M. Colazo, Fang Yu, Mariah G. Bezold, John R. Martin, Nancy L. Cardwell, Jeffrey M. Davidson, Callie M. Thompson, Adrian Barbul, Alyssa H. Hasty, Scott A. Guelcher, Craig L. Duvall, Reactive oxygen species–degradable polythioketal urethane foam dressings to promote porcine skin wound repair, Science Translational Medicine, 10.1126/scitranslmed.abm6586, 14, 641, (2022).
- Aubrey E Woodroof, Gail K Naughton, Fiona M Wood, Robert J Christy, Shanmugasundaram Natesan, William L Hickerson, Path to ‘One and Done’, Journal of Wound Care, 10.12968/jowc.2021.30.10.794, 30, 10, (794-802), (2021).
- Aseel Bin Sawad, Fatema Turkistani, Treatment of venous leg ulcers using bilayered living cellular construct, Journal of Comparative Effectiveness Research, 10.2217/cer-2020-0076, 9, 13, (907-918), (2020).